CD276 and neoplasm: In this study, we construct a tandem CAR molecule targeting 2 tumor-associated antigens, B7-H3 and CD70, and found that TanCAR-T cells distinctly recognize the antigens and exhibited superior antitumor effect when encountering both antigens simultaneously.